Q: You also recently unveiled a new bottling
line. What was behind that move?
Loughlin: The new bottling line is designed
to fill high volume ingestible powders at two-three times the speed previously achieved. This
provides the benefit of additional capacity and
Q: The bottling line was installed in the newly
expanded Union, MO facility. Can you tell us
a bit about the expansion?
Loughlin: The new building is intended to
allow Pharma Tech to focus on new and
established ingestible products manufactured in
a controlled environment more suitable for the
end use of these products. This filling line has
outstanding capability and with the increased
speed we have capacity available to pursue
more programs that require high quality and
competitively priced ingestible powders filled in
Q: What other new areas of growth might be
on the radar screen over the next few years?
Loughlin: Drug/device combinations will likely
be key, with a focus in the inhalation area.
Nutritionals and possibly liquids and semi solids
will also play a part. We will also try to leverage
our dedicated suite strategy to enter other markets
that can leverage our regulatory environment and
our entrepreneurial spirit.
THE BEST DESERVES THE BEST
Since 1992, Marchesini Group USA has been one
of the leading companies supplying the most technologically
advanced packaging solutions to the North American
pharmaceutical and cosmetic industries.
MARCHESINI GROUP USA: PROVIDING THE BEST SINCE 1992.
43 FAIRFIELD PLACE - WES T CALDWELL, NJ 07006 | T. 973 575 7445
About the Company:
such as powders,
solid dosage, plastic
devices, and swabs.